tiprankstipranks
Advertisement
Advertisement
InspireMD reports Q4 EPS (14c), consensus (19c)
PremiumThe FlyInspireMD reports Q4 EPS (14c), consensus (19c)
27d ago
InspireMD sees FY26 revenue $13M-$15M, consensus $14.55M
Premium
The Fly
InspireMD sees FY26 revenue $13M-$15M, consensus $14.55M
27d ago
Is NSPR a Buy, Before Earnings?
Premium
Pre-Earnings
Is NSPR a Buy, Before Earnings?
1M ago
InspireMD announces publication of C-GUARDIANS trial
PremiumThe FlyInspireMD announces publication of C-GUARDIANS trial
3M ago
InspireMD’s New Study on Neuroprotection System: A Potential Game-Changer?
Premium
Company Announcements
InspireMD’s New Study on Neuroprotection System: A Potential Game-Changer?
4M ago
BioCardia appoints Slosman to its Board of Directors
Premium
The Fly
BioCardia appoints Slosman to its Board of Directors
4M ago
InspireMD Reports Record Q3 Revenue with U.S. Launch
PremiumCompany AnnouncementsInspireMD Reports Record Q3 Revenue with U.S. Launch
5M ago
InspireMD reports Q3 EPS (17c) vs (16c) last year
Premium
The Fly
InspireMD reports Q3 EPS (17c) vs (16c) last year
5M ago
InspireMD names Peter Soukas as Chief Medical Officer
Premium
The Fly
InspireMD names Peter Soukas as Chief Medical Officer
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100